Magnesium is marketed as a natural sleep aid, but a new systematic review of 12 randomized controlled trials in adults says the evidence doesn't support it as a routine insomnia treatment. Results were inconsistent across questionnaires, EEG, actigraphy and wearables, and certainty was low to very low. The review used narrative synthesis rather than a meta-analysis because the trials differed so much in forms, doses and populations. Some adults may still see modest subjective benefits, particularly those with low intake. Here's what the paper found, what it didn't, and how to approach a magnesium trial sensibly.
This page is available in